NCT04926181 2025-05-15
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
University of California, San Francisco
Phase 2 Terminated
University of California, San Francisco
Emory University
Tufts Medical Center
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC